Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cts (CTS) EBITDA (2016 - 2025)

Historic EBITDA for Cts (CTS) over the last 16 years, with Q3 2025 value amounting to $20.9 million.

  • Cts' EBITDA rose 29.7% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year increase of 1228.68%. This contributed to the annual value of $71.2 million for FY2024, which is 515.12% down from last year.
  • According to the latest figures from Q3 2025, Cts' EBITDA is $20.9 million, which was up 29.7% from $22.7 million recorded in Q2 2025.
  • In the past 5 years, Cts' EBITDA registered a high of $26.0 million during Q1 2022, and its lowest value of $14.5 million during Q1 2024.
  • Over the past 5 years, Cts' median EBITDA value was $19.0 million (recorded in 2021), while the average stood at $19.8 million.
  • Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 22968.6% in 2021, then plummeted by 3444.87% in 2024.
  • Over the past 5 years, Cts' EBITDA (Quarter) stood at $18.4 million in 2021, then rose by 17.32% to $21.6 million in 2022, then fell by 24.85% to $16.3 million in 2023, then grew by 10.78% to $18.0 million in 2024, then rose by 16.26% to $20.9 million in 2025.
  • Its EBITDA stands at $20.9 million for Q3 2025, versus $22.7 million for Q2 2025 and $16.3 million for Q1 2025.